Human epidermal growth factor receptor 2 borderline mortality in breast cancer patients: Evidence from surveillance, epidemiology, and end results program population-based study Atanu Bhattacharjee, Tapesh Bhattacharyya, Abin Thomas Clinical Epidemiology and Global Health Volume 6, Issue 2, Pages 88-93 (June 2018) DOI: 10.1016/j.cegh.2017.12.005 Copyright © 2017 Terms and Conditions
Fig. 1 Comparison of different types of metastasis and death occurrence in HER2 Positive, HER2Negative, and HER2 Borderline. Clinical Epidemiology and Global Health 2018 6, 88-93DOI: (10.1016/j.cegh.2017.12.005) Copyright © 2017 Terms and Conditions
Fig 2 Comparison of Overall Survival(OS)betweenHER2 Positive, HER2Negative and HER2 Borderline. Clinical Epidemiology and Global Health 2018 6, 88-93DOI: (10.1016/j.cegh.2017.12.005) Copyright © 2017 Terms and Conditions
Fig. 3 Forest Plot with Cox PH Model Performance in HER2 Positive, HER2Negative, and HER2 Borderline. Clinical Epidemiology and Global Health 2018 6, 88-93DOI: (10.1016/j.cegh.2017.12.005) Copyright © 2017 Terms and Conditions